Related by context. All words. (Click for frequent words.) 68 ≥ Grade 63 â ‰ ¥ 63 neutropaenia 60 Darinaparsin 60 neutropenic sepsis 59 permanently discontinue Vectibix 59 haematologic 59 DLTs 59 leucopenia 59 anemia leukopenia 59 syncope fainting 58 genitourinary GU 58 linaclotide treated 58 elevated ALT 58 febrile neutropenia 58 PREZISTA r arm 58 hematologic toxicity 57 Amgen Neulasta R 57 neutropenia dehydration dyspnea 57 Infusion Reactions Severe 57 transaminase elevations 57 receiving XGEVA 57 malignancy HCM 57 incidence ≥ 57 NUEDEXTA arm 57 severe hepatic dysfunction 57 demonstrated antitumor activity 57 cisplatin gemcitabine 57 neutropenic fever 57 hematologic toxicities 56 hematological toxicities 56 neutropenia febrile neutropenia 56 doxorubicin cyclophosphamide 56 headache abdominal pain 56 NSAID induced GI 56 CTCAE 56 4mg/kg 56 oral prednisolone 56 EXJADE 56 neutropenia thrombocytopenia 56 Febrile neutropenia 56 gastrointestinal toxicities 56 adjunctive ABILIFY 56 myalgia arthralgia 56 NS5B polymerase 56 warfarin erythromycin 56 lymphopenia 56 non hematological toxicities 56 overt HE 56 fatigue asthenia 56 pyrexia mucositis sepsis febrile 56 Toxicities 55 bilirubin elevations 55 REYATAZ r arm 55 sublethal 55 sensory neuropathy 55 ‰ ¥ 55 kilogram mg kg 55 recurrent venous thromboembolism 55 adrenal suppression 55 affective psychosis 55 chemotherapy Gislason 55 dermatologic toxicities 55 thrombocytopenia neutropenia 55 prednisone prednisolone plus 55 ALT elevations 55 recurrent herpes labialis 55 insomnia somnolence 55 SSRI SNRI 55 #mg/m# [002] 54 superficial edema 54 % Confidence Interval 54 hyperammonemia 54 IIb IV 54 Chemotherapy induced 54 dermatologic reactions 54 Known hypersensitivity 54 somnolence dizziness 54 cough dyspnea 54 inhaled budesonide 54 CDAD Clostridium difficile 54 pneumocystis carinii pneumonia 54 paronychial inflammation 54 irinotecan cisplatin 54 Amgen Neulasta ® 54 ® lenalidomide 54 Doxepin 54 inorganic arsenic particularly 54 8mg/kg 54 ALT elevation 54 Iodine counteracts 54 hemodilution 54 Hematologic toxicity 54 SGPT 54 reactogenicity 54 hepatotoxicity 54 preoperative PSA 54 profuse watery diarrhea 54 Selective serotonin reuptake inhibitors 54 adjunctive placebo 54 hematological toxicity 54 surgical prophylaxis 54 peripheral sensory neuropathy 54 severe hypersensitivity reactions 54 angioneurotic edema 54 thrombocytopenia anemia 54 leukopenia 54 Flu Cy 53 conventional DMARDs 53 torsade de pointes 53 aminotransferase levels 53 histologic subtype 53 clomipramine 53 #,#,#,# p 53 melphalan prednisone 53 FluCAM arm 53 nephrotoxic 53 laboratory abnormalities 53 mg BID dose 53 opioid naive 53 mucosal inflammation 53 HU# [002] 53 BEXXAR Therapeutic Regimen 53 Non inferiority 53 Secondary endpoints included 53 proctitis 53 unconjugated 53 Leukopenia neutropenia 53 virologic breakthrough 53 hematologic adverse 53 FOLFIRI alone 53 hematological adverse 53 liver decompensation 53 diarrhea dyspepsia 53 CK # administered 53 oxycodone IR 53 pain palliation 53 headache nasopharyngitis 53 Pharmacokinetics PK 53 mg p = 53 symptomatic VTE 53 paroxetine sertraline 53 plasma leptin 53 severe oral mucositis 53 nausea vomiting constipation 52 hematopoietic cancers 52 gemifloxacin 52 dosing frequency 52 hemorrhagic cystitis 52 del 5q MDS 52 T1c 52 prodromal phase 52 x ULN 52 elevated creatinine 52 ziconotide 52 achieved ACR# 52 Study Tanning beds 52 dizziness somnolence 52 prolonged QT interval 52 Aggrastat ® tirofiban hydrochloride 52 Malignant Glioma 52 galiximab 52 #mg/m# [001] 52 salmeterol fluticasone 52 severe exacerbations 52 % CI #.#-#.# [007] 52 desvenlafaxine succinate 52 dizziness nausea headaches 52 nausea diarrhea vomiting 52 Effexor venlafaxine 52 PSA nadir 52 CI -#.# 52 scombroid poisoning 52 CR CRu 52 dose proportionality 52 CR nPR 52 posttreatment 52 acromegalic patients 52 Bayer HealthCare Onyx Pharmaceuticals 52 comorbid anxiety 52 toxicity 52 severe hypoglycaemia 52 nitroprusside 52 fibrosarcoma 52 subchronic 52 Akt activation 52 symptom exacerbation 52 tryptase 52 Dose limiting toxicities 52 3mg/kg 52 linear pharmacokinetics 52 moderately emetogenic 52 somatostatin analog 52 Leukemias 52 nonallergic rhinitis 52 acute toxicity 52 Erythropoietic therapies may 52 organochlorine compounds 52 anagrelide 52 IOP lowering 52 ara C 52 hepatic adverse 52 SPRYCEL ® 52 -#.# mm Hg 52 5alpha reductase 52 HIV HCV coinfected 52 hemoptysis 52 anal intraepithelial neoplasia 52 cyclophosphamide methotrexate 52 zoledronate 52 antiphospholipid antibodies 51 Peginterferon 51 antitumour 51 oral rivaroxaban 51 constipation nausea 51 neuroleptic 51 NATRECOR ® 51 vivo coagulation 51 prolactin elevation 51 Plasma concentrations 51 serum homocysteine 51 Exacerbations 51 amino acid L aspartic 51 intravenous immunoglobulin IVIg 51 extrapyramidal side 51 idiopathic PAH 51 alpha emitting 51 Pemetrexed 51 maximal doses 51 peak plasma concentrations 51 cervical intraepithelial neoplasia 51 dexmethylphenidate 51 mg/m2 dose 51 recurrent ischemia 51 macrolide antibiotic 51 bronchodilatory 51 mercaptopurine 51 mg m² 51 esophageal acid 51 trioxide 51 platelet inhibitor 51 anaphylactic reactions bronchospasm 51 related hematological toxicity 51 fatal anaphylactic 51 endometrial thickness 51 Hepatotoxicity 51 cutaneous lupus 51 prolactin levels 51 Relapsing Remitting Multiple Sclerosis 51 WARNINGS Myopathy Rhabdomyolysis 51 chlorambucil 51 aspartate aminotransferase 51 NPH insulin 51 biochemical relapse 51 oxycodone CR 51 morphometric vertebral fractures 51 abdominal distention 51 Tricyclic antidepressants 51 sievert 51 Soft Tissue Sarcoma 51 severe neutropenia 51 INFERGEN 51 μg mL 51 somnolence fatigue 51 AKT inhibitor 51 CIMZIA ™ 51 SSRI citalopram 51 bacteriuria 51 μg liter 51 anemia neutropenia 51 receptor inhibitor 51 nausea diarrhea fatigue 51 hyperlipemia 51 #μg [001] 51 venlafaxine XR 51 0 document.write sline 51 relapsed MCL 51 coma convulsions 51 serum aminotransferase levels 51 solifenacin 51 fever stomach cramps 51 GLIADEL R Wafer 51 MKC# 51 Vertebral fractures 51 TWYNSTA 51 hypercalcemia 51 AST ALT 51 selective A2A adenosine receptor 51 Navelbine R 51 5-FU/LV 51 dizziness nausea diarrhea 51 urate lowering 51 Decitabine 51 dextromethorphan DM 51 heparanase 51 biologic DMARD 51 BPH benign prostatic 51 Hazard Ratio HR 51 achieved statistical significance 51 Fluorouracil 51 neurotoxicity 51 Mg Uk 51 abdominal cramps nausea 51 Carbamazepine 51 Hcy 51 fatigue nausea vomiting 51 sitaxsentan 51 adjuvant cisplatin 51 colorectal adenoma 50 inecalcitol 50 complement inhibitor eculizumab 50 cardiogenic 50 CG# oncolytic virus 50 saline placebo 50 #ug [002] 50 phototoxicity 50 hormone receptor negative 50 adrenocorticotropic hormone 50 multivariate adjustment 50 perioperatively 50 topical gel formulation 50 Plaquenil 50 nasopharyngitis headache 50 Interferon beta 1a 50 nonhematologic adverse reactions 50 hypercholesterolaemia 50 Fulvestrant 50 sepsis hypothermia 50 oral diclofenac 50 ethyl mesilate 50 thrombocytopenia 50 cardiac toxicity 50 Contains profanity 50 severe hypoglycemia 50 paresthesias 50 gastrointestinal perforation 50 clonidine hydrochloride 50 cramping abdominal pain 50 Oxymorphone ER 50 Ziprasidone 50 undetectable HBV DNA 50 creatine kinase CK 50 MADRS score 50 Pruvel 50 TNF blocker therapy 50 mucocutaneous reactions 50 LT NS# 50 Autoimmune hepatitis 50 % CI #.#-#.# [003] 50 serum triglyceride 50 HBsAg positive 50 symptom flare ups 50 androgen suppression 50 neuropathy sensory 50 CIPN 50 PegIFN RBV 50 overdosage 50 nonnucleoside reverse transcriptase inhibitors 50 tricyclic antidepressant 50 recurrent genital herpes 50 GEMZAR 50 metastatic malignant 50 bullous 50 rizatriptan 50 Navelbine 50 redox active 50 racemic albuterol 50 Acute Bacterial Sinusitis ABS 50 eosinophilia 50 Bipolar Mania 50 receiving ISENTRESS 50 Dietary fat 50 Catapres 50 Temsirolimus 50 QIDS SR 50 Divalproex 50 TMP SMX 50 Intravenous immunoglobulin 50 platelet dysfunction 50 tonsillar hypertrophy 50 lactulose 50 Thrombotic events 50 esthesioneuroblastoma rare form 50 abdominal distension 50 Spoiled Bastard 50 gemcitabine cisplatin 50 #,# DCB 50 T1 hypointense lesions 50 creatine kinase MB 50 impaired insulin secretion 50 EGFRIs 50 Tasigna prolongs 50 interferon alfa 2b 50 Hepatic Impairment 50 liver metastasis 50 clinicopathological features 50 neuropsychiatric adverse 50 ispinesib administered 50 diarrhea vomiting nausea 50 adriamycin 50 Secondary endpoints include 50 ALT flares 50 Magnesium deficiency 50 GH deficiency 50 either Celebrex naproxen 50 capsules USP 50 pharmacokinetic characteristics 50 estramustine 50 Gentle Path compound 50 steroid refractory GvHD 50 Abrupt discontinuation 50 Pegylated interferon 50 tiotropium bromide 50 Hydrochloride Injection 50 excess blasts RAEB 50 mg kg dose 50 liposomal amphotericin B 50 beta carotene supplementation 50 confidence interval #.#-#.# 50 Suicidal ideation 50 pharmacokinetic interactions 50 ergotamine 50 selective modulator 50 nausea somnolence 50 eicosapentaenoic acid ethyl 50 myopathy rhabdomyolysis 50 hypomagnesemia 50 carboplatin AUC 6 50 infusional 50 nausea vomiting diarrhea abdominal 50 trimethoprim sulfamethoxazole 50 Listeria infections 50 polyp recurrence 50 deoxy 50 bone marrow suppression 50 protein excretion 50 digoxin toxicity 50 Estrogen receptor 50 budesonide foam 50 mucositis 50 inhaled tobramycin 50 transdermal estradiol 50 cilengitide 50 symptomatic hypoglycemia 50 C1 INH deficiency 50 folic acid antagonists 50 neutrophil counts 50 Polybrominated 50 baseline HbA1c 50 surgically resectable 50 -#.# mg dL [002] 50 CorVue ™ 50 Hypersensitivity 50 carbon disulfide 50 reproductive toxicity 50 stage IIIb 50 hepatic enzymes 50 Severe cutaneous 50 CYT# QbG# 50 VARIVAX 49 alanine transaminase 49 DMSA 49 interferon alpha IFN 49 embryonic lethality 49 nonexposed 49 recurrent UTI 49 Thrombotic thromboembolic complications 49 Skin rashes 49 hemolytic 49 ovarian hyperstimulation syndrome OHSS 49 Main Outcome Measure 49 QTc prolongation 49 biliary tract cancer 49 Hypotension 49 NOAEL 49 alpha interferons 49 MP4OX 49 piperonyl butoxide 49 ischemia driven 49 HuMax EGFr 49 testicular tumors 49 cardiotoxic 49 Chlamydia trachomatis infection 49 untreated psychosis 49 chemotherapy induced neutropenia 49 clostridium 49 dysuria 49 alanine aminotransferase 49 neutropenia anemia 49 lenalidomide dexamethasone 49 ACR# responses 49 RfD 49 mucosal toxicities 49 CIMZIA TM certolizumab pegol 49 nephrotoxicity 49 elevated prolactin 49 cranial irradiation 49 Ketoacidosis 49 tumor lysis syndrome 49 Oropharyngeal Candidiasis 49 denileukin diftitox 49 Nominal GDP includes 49 TRAIL R1 49 oblimersen 49 labetalol 49 basiliximab 49 tylosin 49 cisplatin chemotherapy 49 Overtreatment 49 teratogenic 49 prucalopride 49 serum cotinine 49 ARB telmisartan 49 Apolipoprotein B 49 aspartate aminotransferase AST 49 hypercalciuria 49 cholecystitis 49 selective serotonin 2C receptor 49 Venlafaxine 49 interleukin IL -6 49 P = .# 49 nausea constipation 49 liver transaminases 49 antithyroid 49 HIV coinfected 49 adrenoceptor 49 Oral corticosteroids 49 initiating antiretroviral therapy 49 SVR# 49 CIN2 + 49 Carbidopa Levodopa 49 Double Blind Randomized 49 NIASPAN 49 ADCS CGIC 49 AUC0 #hr 49 nonfatal MI 49 poststroke depression 49 nitrate nitrite 49 Basal Cell 49 mitoxantrone chemotherapy 49 Almorexant 49 glucuronide 49 #Gy 49 Pharmacokinetic parameters 49 BARACLUDE r 49 oral hypoglycemic 49 conjugated estrogen 49 Danazol 49 Dermatologic toxicities 49 headache nausea diarrhea 49 dasatinib Sprycel ® 49 metabolically inert 49 prochlorperazine 49 extrapyramidal symptoms 49 potassium sparing diuretics 49 serum urate levels 49 Yeast infections 49 APTIVUS r 49 rhinitis sinusitis 49 NAGS deficiency 49 polymyxin B 49 RISPERDAL ® 49 THE COSMOS ROCKS 49 doxorubicin HCl 49 #mg/kg [001] 49 Aclidinium 49 reproductive abnormalities 49 colorectal adenocarcinoma 49 plus medroxyprogesterone acetate 49 elotuzumab 49 lymphoproliferative disorder 49 divalproex sodium 49 breast endometrial 49 transferrin saturation 49 silibinin 49 receiving VELCADE 49 Valproate 49 #mg #mg #mg [002] 49 Immunomodulatory 49 developmental neurotoxicity 49 mania hypomania 49 Active Ulcerative Colitis 49 papillary thyroid carcinoma 49 β blockers 49 protein rFIXFc 49 highly selective endothelin 49 Bicalutamide 49 generalized edema 49 Progressive Multifocal Leukoencephalopathy PML 49 diarrhea headache nausea 49 ZYTIGA 49 Tubulin 49 acute gout flares 49 SSc 49 enteroviral infection 49 acneform rash 49 serum cortisol 49 preterm neonates 49 CP CPPS 49 rufinamide 49 pancytopenia 49 Inventory BPI 49 TIMP 1 49 Opportunistic infections 49 desipramine 49 intravenous bisphosphonates 49 Benzyl 49 steroid dexamethasone 49 gadobutrol 49 phenothiazines 49 glutamyl 49 severe NCI Grades 49 mycophenolate mofetil MMF 49 S/GSK# 49 hypocalcemia 49 Shows Promise Against 49 -#.# mg dL [001] 49 pegylated interferon alfa 49 headache nausea fatigue 49 Episode Recap 49 interstitial pneumonia 49 chronic urticaria 49 pulmonary exacerbation 49 Demonstrates Efficacy 49 bepotastine besilate nasal spray 49 = #.#-#.# 49 mg qd 49 tigecycline 49 Proteinuria 49 bovine thrombin 49 mycophenolate mofetil 49 cidofovir 49 Warfarin Coumadin 49 FOSRENOL ® 49 immunotoxicity 49 histological subtype 49 adjuvant systemic 49 Adenoviral 48 idiopathic pulmonary arterial hypertension 48 renal failure interstitial lung 48 milli grams 48 EEG abnormalities 48 Parnate 48 ISTODAX 48 rhinorrhea 48 intraperitoneally 48 NMIBC 48 PSA kinetics 48 fluticasone salmeterol 48 treatment naive genotype 48 nitrofurantoin 48 ATACAND 48 #.#mg l [001] 48 cadmium cobalt 48 nausea dizziness vomiting 48 Acrolein 48 CYP #D# 48 demyelinating 48 autoantibody positive 48 Asacol R 48 oral antidiabetes 48 atorvastatin #mg 48 Stage IIB 48 Pegylated Liposomal Doxorubicin 48 arterial thromboembolic events 48 HMG CoA reductase inhibitors 48 5FU 48 leukotriene receptor antagonists 48 ribavirin RBV 48 zolmitriptan 48 hydrobromide 48 ceftazidime 48 macrovascular events 48 pneumonitis 48 supine hypertension 48 Eszopiclone 48 Gastrointestinal bleeding 48 TEAEs 48 sulfonamide 48 carmustine 48 Pharmacodynamics 48 mg Proellex 48 oral levofloxacin 48 DFMO 48 limiting toxicity 48 idarubicin 48 fluorouracil 48 Mount Hood Gubele 48 abacavir lamivudine 48 agitation irritability 48 diarrhea nausea vomiting 48 intramuscularly 48 plasma HCV RNA 48 dose dexamethasone 48 fructose intolerance 48 fluticasone propionate FP 48 ovarian carcinoma 48 #ng/ml 48 light headedness dizziness 48 systemic hypotension 48 Streptococcus pneumoniae S. pneumoniae 48 MAXALT 48 Cyclophosphamide 48 Nilotinib 48 unfractionated heparin UFH 48 node metastases 48 Creatinine 48 Rotavirus infection 48 gestational diabetes mellitus GDM 48 1mg 48 decompensation 48 vasodilatory 48 hepatic toxicity 48 liver enzymes ALT 48 Alkaline Phosphatase 48 chronic idiopathic thrombocytopenic purpura 48 PSADT 48 nausea cramps 48 Actor Abraham Benrubi 48 Clemens Injections 48 Lamotrigine 48 beta lactam antibiotic 48 antiphospholipid syndrome 48 Adefovir 48 LANTUS ® 48 myelosuppression 48 symptomatic paroxysmal AF 48 Phase III cSSSI 48 nausea vomiting dizziness 48 immune modulator 48 Cimzia TM 48 plasma pharmacokinetics 48 serum CRP 48 lichen planus 48 axillary node 48 headache dizziness fatigue 48 Stent thrombosis 48 bleomycin 48 mimics estrogen 48 imatinib therapy 48 dose limiting toxicities 48 Navelbine ® 48 antiemetics 48 p# antigen 48 hyperosmolar 48 bacterial prostatitis 48 patients receiving ERBITUX 48 Hormone Refractory Prostate Cancer 48 parkinsonian 48 thrombocytosis 48 hyperprolactinemia 48 maternal serum 48 inhaled fluticasone 48 Evidence Therapeutic Level 48 ursodeoxycholic acid 48 chemoradiation therapy 48 renal scarring 48 subsyndromal 48 acitretin 48 creatinine ratio 48 neutropenic patients 48 ß blockers 48 pharmacodynamic PD 48 fatigue abdominal pain 48 Postmarketing 48 p = .# [002] 48 AML MDS 48 antiepileptics 48 Severe hypersensitivity reactions 48 TNF alpha antagonists 48 lactate dehydrogenase LDH 48 alpha 2a 48 PEG IFN 48 conjugated equine estrogen 48 alkylating agent 48 guanfacine extended release 48 parkinsonian symptoms 48 NB S# strontium malonate 48 nadolol 48 AUC0 48 nocturnal hypoglycaemia 48 intact parathyroid hormone 48 norethindrone acetate 48 convulsions tremors 48 CI #.#-#.# [001] 48 Ropinirole 48 Helicobacter pylori eradication 48 hepatic failure 48 dimeglumine 48 oxymorphone IR 48 interstitial brachytherapy 48 Y BOCS 48 pyridostigmine 48 opioid mediated 48 ATV RTV 48 prostate carcinoma 48 IFN beta 48 aplindore 48 piperacillin tazobactam 48 clinically asymptomatic 48 unmeasured confounders 48 Paxil paroxetine 48 aspirin clopidogrel 48 See CLINICAL PHARMACOLOGY 48 captopril 48 polybrominated 48 distribution metabolism excretion 48 depressive symptom 48 KRAS mutant tumors 48 Acute pancreatitis 48 dose dependently 48 citalopram hydrobromide 48 nicardipine 48 serum phosphate 48 Index CDAI 48 hematologic abnormalities 48 Phenytoin 48 non hematologic toxicities 48 INTEGRILIN ® 48 toxicities 48 recurrent DVT 48 Intrathecal 48 Nausea vomiting diarrhea 48 Headache nausea 48 corticosteroid therapy 48 rheumatoid arthritis HUMIRA 48 thromboembolic disease 48 μg kg 48 pCR 48 Heavy menstrual bleeding 48 thiopurine 48 serum urate 48 DDT dieldrin 48 HER2 positivity 48 skeletal metastases 48 Cinacalcet HCl 48 rosuvastatin #mg 48 didanosine associated 48 mitochondrial toxicity 48 gastrointestinal ulcers 48 ricin toxin botulinum toxin 48 serum magnesium 48 syncopal 48 Primary endpoints 48 rhITF 48 NDC #-#-# [001] 48 ULTRAM R 48 Angioedema 48 steroid refractory ulcerative 48 cells uL 48 renal toxicity 48 ® pramlintide acetate 48 anxiolytic 48 pharmacologically active isomer 48 diethanolamine 48 oral prodrug 48 #mg/kg [002] 48 inhibin B 48 labetuzumab 48 cisplatin resistant 48 deferoxamine 48 myeloablative 48 hypogonadotropic hypogonadism 48 polycyclic aromatic hydrocarbon 48 attain statistical significance 48 pmol L 48 Neutropenia 48 paclitaxel poliglumex 48 Renal impairment 48 caspofungin 48 isoenzyme 48 Randomized Phase 48 pulmonary dysfunction 48 Peripheral edema 48 mu g 48 fetal malformations 48 μg L 48 clinically meaningful differences 48 hyperalgesia 48 Hypoglycaemia 48 trans palmitoleate 48 Interferon Beta 48 gastrointestinal disturbances 48 liposomal formulation 48 dihydroergotamine DHE 48 experienced hypomagnesemia 48 pyrimidine nucleoside analog 47 ketoconazole 47 metachronous 47 BUPHENYL R sodium phenylbutyrate 47 regression coefficient 47 atypical antipsychotic medications 47 lamictal 47 tiagabine 47 adverse perinatal 47 baseline LDH 47 durable remissions 47 subthreshold 47 arbaclofen 47 CIN3 47 antiangiogenic agent 47 aprepitant 47 bipolar mania trials 47 Telintra 47 prenatal exposures 47 AUA Symptom Score 47 sinus tachycardia 47 HBeAg 47 lanthanum carbonate 47 invasive carcinomas 47 THE WONDER PETS 47 intranasally administered 47 sapropterin dihydrochloride Phase 47 terazosin 47 buproprion 47 EFFEXOR XR 47 mg eq 47 serum retinol 47 hepatic insufficiency 47 ULTRAM ® 47 alpha hydroxyprogesterone caproate 47 Bevacizumab Avastin 47 Follicular Lymphoma 47 primidone 47 Click TH/TRADING# 47 Levels Linked 47 refractory gout 47 aminotransferase 47 delayed gastric emptying 47 endoplasmic reticulum stress 47 cytopenias 47 unresectable HCC 47 ug kg 47 dosing cohort 47 placebo PBO 47 allergic dermatitis 47 #,# dimethyl 47 Non Alcoholic Steatohepatitis 47 daily subcutaneous injections 47 ecotoxicity 47 maintaining Hb 47 teratogenic effects 47 Sheer Miracle received 47 6R BH4 47 eszopiclone 47 % CI #.#-#.# [008] 47 prednisone prednisolone 47 Elevated serum 47 antiresorptive 47 adrenocortical 47 serum calcium 47 tumor necrosis 47 Sleep disturbances 47 riociguat 47 intratumoral 47 hMG 47 TMPRSS2 ERG fusion 47 log# reduction 47 urinary excretion 47 Lactic acidosis 47 alanine aminotransferase ALT 47 nmol 47 ischemia induced 47 vinorelbine tartrate 47 related CMV Retinitis 47 Lanthanum carbonate 47 quinoline 47 symptomatic pulmonary embolism 47 ß carotene 47 mRS 47 ANCA associated 47 favorable pharmacokinetic 47 asymptomatic bacteriuria 47 hepatic dysfunction 47 pegylated alpha interferon 47 Prognostic significance 47 amoxicillin clavulanate 47 radiation dermatitis 47 tardive 47 plus 5-FU/LV 47 itraconazole Sporanox 47 Nocturia 47 TNF antagonist 47 pancreas esophagus 47 conjugated estrogens 47 ototoxicity 47 topical calcineurin inhibitors 47 selectively binds 47 containing abacavir 47 cause drowsiness dizziness 47 Drospirenone 47 advanced adenoma 47 picocurie 47 ADCS ADL 47 induration 47 #.#ng/ml 47 FLOMAX 47 LPS induced 47 nonsevere